Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
Breast Cancer Res Treat ; 119(3): 559-74, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19288189

ABSTRACT

Glypican-3 (GPC3) is a proteoglycan involved in proliferation and cell survival. Several reports demonstrated that GPC3 is downregulated in some tumors, such as breast cancer. Previously, we determined that GPC3 reexpression in the murine mammary adenocarcinoma LM3 cells induced an impairment of their invasive and metastatic capacities, associated with a decrease of their motility and an increase of their cell death. We demonstrated that GPC3 inhibits canonical Wnt signaling, as well as it activates non canonical pathway. Now, we identified signaling pathways responsible for the pro-apoptotic role of GPC3 in LM3 cells. We found for the first time that GPC3 inhibits the PI3K/Akt anti-apoptotic pathway while it stimulates the p38MAPK stress-activated one. We report a concomitant modulation of CDK inhibitors as well as of pro- and anti-apoptotic molecules. Our results provide new clues regarding the mechanism involved in the modulation induced by GPC3 of mammary tumor cell growth and survival.


Subject(s)
Adenocarcinoma/metabolism , Apoptosis/physiology , Breast Neoplasms/metabolism , Glypicans/metabolism , Signal Transduction/physiology , Adenocarcinoma/genetics , Animals , Blotting, Western , Breast Neoplasms/genetics , Cell Line, Tumor , Cell Separation , Female , Flow Cytometry , Gene Expression , Gene Expression Regulation, Neoplastic , Glypicans/genetics , Immunohistochemistry , Mice , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Reverse Transcriptase Polymerase Chain Reaction , p38 Mitogen-Activated Protein Kinases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...